Literature DB >> 10098840

Fyn tyrosine kinase reduces the ethanol inhibition of recombinant NR1/NR2A but not NR1/NR2B NMDA receptors expressed in HEK 293 cells.

D L Anders1, T Blevins, G Sutton, S Swope, L J Chandler, J J Woodward.   

Abstract

NMDA receptors are potentiated by phosphorylation in a subunit- and kinase-specific manner. Both native and recombinant NMDA receptors are inhibited by behaviorally relevant concentrations of ethanol. Whether the phosphorylation state of individual subunits modulates the ethanol sensitivity of these receptors is not known. In this study, the effects of Fyn tyrosine kinase on the ethanol sensitivity of specific recombinant NMDA receptors expressed in HEK 293 cells were investigated. Whole-cell mode patch clamp and ratiometric calcium imaging demonstrated that the degree of ethanol inhibition of NR1/NR2B receptors was unaffected by Fyn tyrosine kinase. In contrast, the inhibition of NR1/NR2A receptors by ethanol (100 mM) was significantly reduced under conditions of enhanced Fyn-mediated tyrosine phosphorylation of the NR2A subunit. This effect was not observed at lower concentrations of ethanol (< or = 50 mM). These results suggest that tyrosine phosphorylation of specific NMDA receptors by Fyn tyrosine kinase may regulate the sensitivity of these receptors to the sedative/hypnotic concentrations of ethanol.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098840     DOI: 10.1046/j.1471-4159.1999.721389.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  Interactions among positions in the third and fourth membrane-associated domains at the intersubunit interface of the N-methyl-D-aspartate receptor forming sites of alcohol action.

Authors:  Hong Ren; Yulin Zhao; Donard S Dwyer; Robert W Peoples
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

2.  Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors.

Authors:  Yuwei Liu; Chaoying Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

3.  Effects of ethanol on phosphorylation site mutants of recombinant N-methyl-D-aspartate receptors.

Authors:  Minfu Xu; Corigan Thetford Smothers; John J Woodward
Journal:  Alcohol       Date:  2010-12-15       Impact factor: 2.405

4.  Different sites of alcohol action in the NMDA receptor GluN2A and GluN2B subunits.

Authors:  Yulin Zhao; Hong Ren; Donard S Dwyer; Robert W Peoples
Journal:  Neuropharmacology       Date:  2015-06-04       Impact factor: 5.250

5.  Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edge.

Authors:  Ana Kostic; Michael P Sheetz
Journal:  Mol Biol Cell       Date:  2006-04-05       Impact factor: 4.138

6.  Inhibition by ethanol of NMDA-induced responses and acute tolerance to the inhibition in rat sympathetic preganglionic neurons in vitro and in vivo.

Authors:  Hsun Hsun Lin; Wei-Kung Hsieh; Jing-Yi Shiu; Ted H Chiu; Chih-Chia Lai
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

7.  Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta.

Authors:  Minfu Xu; L Judson Chandler; John J Woodward
Journal:  Alcohol       Date:  2008-06-17       Impact factor: 2.405

Review 8.  Ethanol effects on N-methyl-D-aspartate receptors in the bed nucleus of the stria terminalis.

Authors:  Tiffany A Wills; Danny G Winder
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

9.  Dephosphorylation of GluN2B C-terminal tyrosine residues does not contribute to acute ethanol inhibition of recombinant NMDA receptors.

Authors:  Benjamin A Hughes; C Thetford Smothers; John J Woodward
Journal:  Alcohol       Date:  2013-01-26       Impact factor: 2.405

Review 10.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.